they cannot totally bypass APL as APL has the collection and gathering for most. Time will tell how things go but would think positive for both producers - higher prices received - and MLPs with higher volumes. there is little incentive for producers to build their own distillation otwers because of the cost including everything else and ther need for pipelines downstream.
Who cares as splits add absolutely no value. With spreads worth .01 and commissions as little #$%$ make no difference for 1 share at $80 or 2 at $40.
AMPE has said several times the entire report would only be released in a journal or similar to give maximum push to the results. The is Macaluso and his ideas. Optina is going to completion, just a bit strange - again.
EPD only uses storage for their own account. They are not in the storage for rent business. The winners here are those with dockage. NS for one has lots of space in Corpus. EPD has a headstart on the production of condensates. NGLS and others will benefit.
Super - If you were looking for a site visit you need to think some more. Reports are put together using a computer matrix and anecdotal data gathered during a phone conversation. There is no attempt at a lid on a price. Targets are simply that and would not include any Medicare reimbursements etc. because AMPE does not have an approved drug to apply for reimbursement. Personally am simply pleased there is a second report (Aegis means nothing in ther investing world) as this gives validation to Citi.
As Grindle said $14 is a HUGE number north of $8. And a move to that area would put a bunch of pressure on the shorts. The game is still the same - get one of ther drugs to market with enough penetration to provide positive cash flow before they burn through the existing cash. Other bios actuially have approved drugs/procedures and are in the same situation. IMO AMPE sells off something and eventually uses that cvash to guarantee they get to market for Ampion or Optina.
Grindle/Bill - Agree 100%. Optina is nice but definately a little brother. As to finding patients - seems they simply did not look really hard. It takes $$ to find and search out patients and AMPE did not put that in their budget. Also for those that are going blind being in a study where #1 you might get a placebo and #2 a drug that does not work seem like something where I would go to a treatment that was at least working a bit. The stoppage does not prove anything but it is indeed strange.
It was simply not totally credible. The study was supposed to be double blind. Now in a study that is not complete for most participants they change everything and provide Optina at the request of the site investagators? The site investagators should not have known who is getting what. always seems like AMPE is doing studies in a way different from normal procedure.
Do not get me wrong, I am long AMPE as is my family in a big way. Just find the way they put out information to be very strange. Maybe clear was not the right word but strange does apply. I have no problem with the study taking longer, but why are they xchanging it in the middle?
The Adam article is actually funny. What is not is AMPE continues to have strange press releases and is lacking in clear information. The Adam article is absolute bull puckey and is truly laughable. The AMPE press release on Optina could be kindly called confusing at best.
The pipeline will take 2 1/2 years to complete. Design probably 6-8 months and then they start spending $$. Thus no hurry to raise $$ for the pipeline for a while.
Very simple. ETE owns about 50M ETP units and the IDRs. It does not own ETP. That means for every .01 paid out to ETP holders that ETE holders get .01 too. Then remember to pay for the $2B (just a guess) ETP will need to issue lots of units - in the area of 18 MILLION. That means an extra 75 Million $$ each year for ETE holders.
It is called leverage! Also ETE is not the main company. Probably thinking of it as the managing partner would be helpful. That leverage is why ETE pays out at a sub 3% distribution and ETP about 6%. The ETE distribution will grow faster than ETP and can grow even if ETPs does not when units are issued.
Do a bit of reading from the National Association of Publically Traded Partnerships and their primer called MLP 101. You obviously do not understand things like ETE pays no dividend and has units instead of shares. BIG DIFFERENCE!
Actually floodkid you might be the stupid one as ETP does not pay a dividend. Need to read a bit on MLPs and how they are different. Do understand lots of worse boards like Realty Income, but there is an entire board where people discuss nothing except MLPs.
As to Ford - I own it. Do not bother with tgheir message board.
With propane - EPD produces the propane and sells it on their own account. With condensate most exports will come from somewhere other than EPDs facitity in Houston because of ship issues. The exporters there would probably simply transport and store (EPD and others). The producers would generally retain title to the oil but of course each deal is made on its own. Personally why own the stuff when you can get paid a toll for transporting and handling it! No commodity risk in the manner.
If we have a bit of a move down and the AMZ dropps by say 10% (which has happened three times in the last 5 years) then MLPL will drop by a bit over twice that amount. Duh!
What does exporting a very light oil have to do with becoming energy independent? The winners on this are the producers, processors, and exporters (of which EPD is only 1 of about 20 companies). It will also give incentive to produce more NG to use at home becasue NG producers will now have a market for their production. The only loser is refineries who now will need to compete with product that will command a world based price.
The effect on the general population would be zero to a bit positive. Zero in that prices for oil based products should not change and positive in that thousands of good paying jobs in the USA will be created. Those people will pay taxes and buy things creating more jobs.
Marv - 2 new CEFs that need to invest about 1.2B into MLPs. One last week and one today. That could easily account for the volume.
Found some interesting numbers from MS. For the period of 2014 thru 2016YE MWE has organic newbuild committments equalling almost every other MLP except KMP and EPD. MWE volume and price IMO has gone up because it had simply lagged almost every other midstream player. It is now at a reasonable price. take a look at the moves for the others. MWE simply catching up a bit with the others in the yield arena. you also have had a bit of new institutional money coming into the market with another $600M this week. With that money you need to buy some yield. Understand the move ETE etc. have made but a CEF simply cannot pay a yield under the 5% average for the area. Needs the MWEs etc. to make the portfolio. Also the last bond was investment erated (know only for 10 years) and MWE due an upgrade as now in the 60% equity area. Would think a temporary slowdown for equity issuance unless the new CEFs want a chunk at an ATM price or maybe they already have bought in. ???
Got to remember the largest grower in the midstream area in 2014 by $$ amount will be RGP, but most of that acquisition. money is right on!
Since it appears they never shorted little to expect. Report never came out. Hedgeye is simply BS.